Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,516
Closed -$199K 1909
2025
Q4
$199K Buy
+28,516
New +$179K ﹤0.01% 1388
2025
Q1
Sell
-255,617
Closed -$3.1M 1818
2024
Q4
$3.1M Buy
+255,617
New +$3.58M 0.02% 574
2024
Q1
Sell
-103,375
Closed -$2.08M 1814
2023
Q4
$2.08M Buy
103,375
+77,172
+295% +$1.31M 0.01% 564
2023
Q3
$486K Sell
26,203
-22,939
-47% -$500K ﹤0.01% 1255
2023
Q2
$1.07M Buy
+49,142
New +$888K 0.01% 1077
2022
Q4
Sell
-391,837
Closed -$5.47M 1963
2022
Q3
$5.47M Buy
391,837
+194,733
+99% +$3.92M 0.07% 371
2022
Q2
$4.75M Buy
+197,104
New +$5.29M 0.06% 424
2021
Q4
Sell
-36,466
Closed -$1.58M 2455
2021
Q3
$1.58M Buy
36,466
+28,719
+371% +$1.25M 0.02% 823
2021
Q2
$357K Buy
+7,747
New +$358K ﹤0.01% 1635
2021
Q1
Sell
-7,222
Closed -$286K 2435
2020
Q4
$286K Sell
7,222
-372
-5% -$13.8K ﹤0.01% 1566
2020
Q3
$297K Buy
+7,594
New +$291K 0.01% 1292
2020
Q2
Sell
-8,034
Closed -$269K 1935
2020
Q1
$269K Buy
+8,034
New +$264K 0.01% 687

Other funds holding NEOG

Michael Gelband's NEOG Position: Q1 2026 in Review

Michael Gelband sold out of Neogen (NEOG) in Q1 2026, closing a stake of 28,516 shares — an estimated $199K sold.

Michael Gelband first reported a position in NEOG in Q1 2020 and held it in 12 quarters. The position peaked at $5.47M in Q3 2022. 307 funds tracked by Wall St. Rank hold NEOG as of Q1 2026.

  • Michael Gelband reported no remaining Neogen position as of Q1 2026 after selling out during the quarter.
  • Michael Gelband sold 28,516 Neogen shares in Q1 2026, an estimated $199K.
  • Michael Gelband first reported a position in Neogen in Q1 2020 and held it in 12 quarters.
  • Michael Gelband's Neogen position peaked at $5.47M in Q3 2022.
  • 307 funds tracked by Wall St. Rank held Neogen as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.